Kardell O, Gronauer T, von Toerne C, Merl-Pham J, Konig A, Barth T
J Proteome Res. 2025; 24(3):1017-1029.
PMID: 39918541
PMC: 11894660.
DOI: 10.1021/acs.jproteome.4c00644.
Brombacher E, Schilling O, Kreutz C
Sci Rep. 2025; 15(1):3189.
PMID: 39863642
PMC: 11762699.
DOI: 10.1038/s41598-025-87256-5.
Pauper M, Hentschel A, Tiburcy M, Beltran S, Ruck T, Schara-Schmidt U
Biomolecules. 2025; 15(1).
PMID: 39858524
PMC: 11763865.
DOI: 10.3390/biom15010130.
Prakash A, Collins A, Vilmovsky L, Fexova S, Jones A, Vizcaino J
J Proteome Res. 2025; 24(2):685-695.
PMID: 39764611
PMC: 11811993.
DOI: 10.1021/acs.jproteome.4c00788.
Fochtman D, Marczak L, Pietrowska M, Wojakowska A
J Extracell Vesicles. 2024; 13(12):e70020.
PMID: 39692094
PMC: 11653094.
DOI: 10.1002/jev2.70020.
Proteomic analysis of non-muscle invasive and muscle invasive bladder cancer highlights distinct subgroups with metabolic, matrisomal, and immune hallmarks and emphasizes importance of the stromal compartment.
Dinh T, Rogg M, Cosenza-Contreras M, Li M, Zirngibl M, Pinter N
J Pathol. 2024; 265(1):41-56.
PMID: 39582373
PMC: 11638668.
DOI: 10.1002/path.6367.
Assessing and mitigating batch effects in large-scale omics studies.
Yu Y, Mai Y, Zheng Y, Shi L
Genome Biol. 2024; 25(1):254.
PMID: 39363244
PMC: 11447944.
DOI: 10.1186/s13059-024-03401-9.
Combining Data Independent Acquisition With Spike-In SILAC (DIA-SiS) Improves Proteome Coverage and Quantification.
Welter A, Gerwien M, Kerridge R, Alp K, Mertins P, Selbach M
Mol Cell Proteomics. 2024; 23(10):100839.
PMID: 39271013
PMC: 11795695.
DOI: 10.1016/j.mcpro.2024.100839.
Unveil Intrahepatic Cholangiocarcinoma Heterogeneity through the Lens of Omics and Multi-Omics Approaches.
Porreca V, Barbagallo C, Corbella E, Peres M, Stella M, Mignogna G
Cancers (Basel). 2024; 16(16).
PMID: 39199659
PMC: 11352949.
DOI: 10.3390/cancers16162889.
Deep Plasma Proteomics with Data-Independent Acquisition: Clinical Study Protocol Optimization with a COVID-19 Cohort.
Ward B, Pyr Dit Ruys S, Balligand J, Belkhir L, Cani P, Collet J
J Proteome Res. 2024; 23(9):3806-3822.
PMID: 39159935
PMC: 11385417.
DOI: 10.1021/acs.jproteome.4c00104.
Effect of dynamic exclusion and the use of FAIMS, DIA and MALDI-mass spectrometry imaging with ion mobility on amyloid protein identification.
Aguilan J, Lim J, Racine-Brzostek S, Fischer J, Silvescu C, Cornett S
Clin Proteomics. 2024; 21(1):47.
PMID: 38961380
PMC: 11223398.
DOI: 10.1186/s12014-024-09500-w.
µPhos: a scalable and sensitive platform for high-dimensional phosphoproteomics.
Oliinyk D, Will A, Schneidmadel F, Bohme M, Rinke J, Hochhaus A
Mol Syst Biol. 2024; 20(8):972-995.
PMID: 38907068
PMC: 11297287.
DOI: 10.1038/s44320-024-00050-9.
Data-Independent Acquisition: A Milestone and Prospect in Clinical Mass Spectrometry-Based Proteomics.
Frohlich K, Fahrner M, Brombacher E, Seredynska A, Maldacker M, Kreutz C
Mol Cell Proteomics. 2024; 23(8):100800.
PMID: 38880244
PMC: 11380018.
DOI: 10.1016/j.mcpro.2024.100800.
Statistical Testing for Protein Equivalence Identifies Core Functional Modules Conserved across 360 Cancer Cell Lines and Presents a General Approach to Investigating Biological Systems.
Ergin E, Myung J, Lange P
J Proteome Res. 2024; 23(6):2169-2185.
PMID: 38804581
PMC: 11166143.
DOI: 10.1021/acs.jproteome.4c00131.
Optimizing differential expression analysis for proteomics data via high-performing rules and ensemble inference.
Peng H, Wang H, Kong W, Li J, Goh W
Nat Commun. 2024; 15(1):3922.
PMID: 38724498
PMC: 11082229.
DOI: 10.1038/s41467-024-47899-w.
Ultra-fast label-free quantification and comprehensive proteome coverage with narrow-window data-independent acquisition.
Guzman U, Martinez-Val A, Ye Z, Damoc E, Arrey T, Pashkova A
Nat Biotechnol. 2024; 42(12):1855-1866.
PMID: 38302753
PMC: 11631760.
DOI: 10.1038/s41587-023-02099-7.
Robust, Precise, and Deep Proteome Profiling Using a Small Mass Range and Narrow Window Data-Independent-Acquisition Scheme.
Frohlich K, Furrer R, Schori C, Handschin C, Schmidt A
J Proteome Res. 2024; 23(3):1028-1038.
PMID: 38275131
PMC: 10913089.
DOI: 10.1021/acs.jproteome.3c00736.
Protocol of the HISTOTHERM study: assessing the response to hyperthermia and hypofractionated radiotherapy in recurrent breast cancer.
Thomsen A, Sahlmann J, Bronsert P, Schilling O, Poensgen F, May A
Front Oncol. 2024; 13:1275222.
PMID: 38169879
PMC: 10759986.
DOI: 10.3389/fonc.2023.1275222.
Multicenter Collaborative Study to Optimize Mass Spectrometry Workflows of Clinical Specimens.
Kardell O, von Toerne C, Merl-Pham J, Konig A, Blindert M, Barth T
J Proteome Res. 2023; 23(1):117-129.
PMID: 38015820
PMC: 10775142.
DOI: 10.1021/acs.jproteome.3c00473.
Using proteomics for stratification and risk prediction in patients with solid tumors.
Werner T, Fahrner M, Schilling O
Pathologie (Heidelb). 2023; 44(Suppl 3):176-182.
PMID: 37999758
DOI: 10.1007/s00292-023-01261-x.